Acute Lymphoblastic Leukemia — Trials

Acute Lymphoblastic Leukemia — Trials · CancerIndex

Clinical trials

Registered studies

2,037 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 546
Recruiting: 330
Ph III recruiting: 26
Growth YoY: −10%
Industry share: 13%
Top sponsor: City of Hope Medical Center
Termination share: 33.3%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (268)

clinicaltrialsPublishedShowing 101–150 of 154 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT05940961	Inotuzumab Ozogamicin in the Treatment of MRD+ After HSCT of ALL	recruiting	Phase 2	42	Sheng-Li Xue, MDOTHER	1	Nov 21, 2025	clinicaltrials
NCT06128070	Ruxolitinib With Tacrolimus and Methotrexate for the Prevention of Graft Versus Host Disease in Pediatric and Young Adult Patients Undergoing Allogeneic Hematopoietic Cell Transplant for Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, or Myelodysplastic Syndrome	recruiting	Phase 2	40	City of Hope Medical CenterOTHER	1	Oct 31, 2025